We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
PSTI.TA

Price
1465.00
Stock movement up
+3.00 (0.21%)
Company name
Pluristem
Exchange
(TA
,
Currency
ILA
)
Sector
Healthcare >
Biotechnology & Medical Research
Market cap
47.39B
Ent value
47.40B
Price/Sales
202518.09
Price/Book
1180.51
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-30.24%
3 year return
32.36%
5 year return
0.91%
10 year return
-34.69%
Last updated: 2025-04-12

DIVIDENDS

PSTI.TA does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales202518.09
Price to Book1180.51
EV to Sales202583.02

FINANCIALS

Per share

Loading...
Per share data
Current share count32.35M
EPS (TTM)-1.45
FCF per share (TTM)-1.17

Income statement

Loading...
Income statement data
Revenue (TTM)234.00K
Gross profit (TTM)0.00
Operating income (TTM)-47.30M
Net income (TTM)-46.80M
EPS (TTM)-1.45
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-20212.82%
Profit margin (TTM)-20002.14%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash23.79M
Net receivables0.00
Total current assets64.31M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets79.13M
Accounts payable2.39M
Short/Current long term debt0.00
Total current liabilities7.82M
Total liabilities38.98M
Shareholder's equity40.14M
Net tangible assets38.09M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-37.67M
Capital expenditures (TTM)123.00K
Free cash flow (TTM)-37.79M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-116.60%
Return on Assets-59.15%
Return on Invested Capital-74.21%
Cash Return on Invested Capital-59.93%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1411.00
Daily high1559.00
Daily low1411.00
Daily Volume15K
All-time high192700.00
1y analyst estimate-
Beta1.91
EPS (TTM)-1.45
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
PSTI.TAS&P500
Current price drop from All-time high-99.24%-14.41%
Highest price drop-99.90%-56.47%
Date of highest drop30 Oct 20239 Mar 2009
Avg drop from high-72.29%-11.07%
Avg time to new high175 days12 days
Max time to new high3081 days1805 days
COMPANY DETAILS
PSTI.TA (Pluristem) company logo
Marketcap
47.39B
Marketcap category
Large-cap
Description
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18 for incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as a solution for the treatment of acute radiation syndrome. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.
Employees
153
Investor relations
-
CEO
Country
Israel
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found